Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylocaine for pain reduction during nasopharyngeal swabs in children
NCT04901065Phase 3Completed
- Start
- May 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in pain. Primary endpoint: Pain during the procedure. Started May 2021; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
pain
Beyond the preview
Go deeper on NCT04901065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04901065.